What is a poor predictor for response to omalizumab?
•
3 min read
While omalizumab proves effective for many patients with chronic spontaneous urticaria and severe allergic asthma, a significant percentage of individuals experience a poor or non-existent response. Identifying what is a poor predictor for response to omalizumab is crucial for clinicians to manage patient expectations and optimize therapeutic outcomes.
